Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal Cancer.


Journal

Cellular and molecular gastroenterology and hepatology
ISSN: 2352-345X
Titre abrégé: Cell Mol Gastroenterol Hepatol
Pays: United States
ID NLM: 101648302

Informations de publication

Date de publication:
2023
Historique:
received: 01 09 2022
revised: 09 04 2023
accepted: 10 04 2023
medline: 20 6 2023
pubmed: 22 4 2023
entrez: 21 04 2023
Statut: ppublish

Résumé

Improving clinical management of early stage colorectal cancers (T1CRCs) requires a better understanding of their underlying biology. Accumulating evidence shows that cancer-associated fibroblasts (CAFs) are important determinants of tumor progression in advanced colorectal cancer (CRC), but their role in the initial stages of CRC tumorigenesis is unknown. Therefore, we investigated the contribution of T1CAFs to early CRC progression. Primary T1CAFs and patient-matched normal fibroblasts (NFs) were isolated from endoscopic biopsy specimens of histologically confirmed T1CRCs and normal mucosa, respectively. The impact of T1CAFs and NFs on tumor behavior was studied using 3-dimensional co-culture systems with primary T1CRC organoids and extracellular matrix (ECM) remodeling assays. Whole-transcriptome sequencing and gene silencing were used to pinpoint mediators of T1CAF functions. In 3-dimensional multicellular cultures, matrix invasion of T1CRC organoids was induced by T1CAFs, but not by matched NFs. Enhanced T1CRC invasion was accompanied by T1CAF-induced ECM remodeling and up-regulation of CD44 in epithelial cells. RNA sequencing of 10 NF-T1CAF pairs revealed 404 differentially expressed genes, with significant enrichment for ECM-related pathways in T1CAFs. Cathepsin H, a cysteine-type protease that was specifically up-regulated in T1CAFs but not in fibroblasts from premalignant lesions or advanced CRCs, was identified as a key factor driving matrix remodeling by T1CAFs. Finally, we showed high abundance of cathepsin H-expressing T1CAFs at the invasive front of primary T1CRC sections. Already in the earliest stage of CRC, cancer cell invasion is promoted by CAFs via direct interactions with epithelial cancer cells and stage-specific, cathepsin H-dependent ECM remodeling. RNA sequencing data of the 10 NF-T1CAF pairs can be found under GEO accession number GSE200660.

Sections du résumé

BACKGROUND & AIMS
Improving clinical management of early stage colorectal cancers (T1CRCs) requires a better understanding of their underlying biology. Accumulating evidence shows that cancer-associated fibroblasts (CAFs) are important determinants of tumor progression in advanced colorectal cancer (CRC), but their role in the initial stages of CRC tumorigenesis is unknown. Therefore, we investigated the contribution of T1CAFs to early CRC progression.
METHODS
Primary T1CAFs and patient-matched normal fibroblasts (NFs) were isolated from endoscopic biopsy specimens of histologically confirmed T1CRCs and normal mucosa, respectively. The impact of T1CAFs and NFs on tumor behavior was studied using 3-dimensional co-culture systems with primary T1CRC organoids and extracellular matrix (ECM) remodeling assays. Whole-transcriptome sequencing and gene silencing were used to pinpoint mediators of T1CAF functions.
RESULTS
In 3-dimensional multicellular cultures, matrix invasion of T1CRC organoids was induced by T1CAFs, but not by matched NFs. Enhanced T1CRC invasion was accompanied by T1CAF-induced ECM remodeling and up-regulation of CD44 in epithelial cells. RNA sequencing of 10 NF-T1CAF pairs revealed 404 differentially expressed genes, with significant enrichment for ECM-related pathways in T1CAFs. Cathepsin H, a cysteine-type protease that was specifically up-regulated in T1CAFs but not in fibroblasts from premalignant lesions or advanced CRCs, was identified as a key factor driving matrix remodeling by T1CAFs. Finally, we showed high abundance of cathepsin H-expressing T1CAFs at the invasive front of primary T1CRC sections.
CONCLUSIONS
Already in the earliest stage of CRC, cancer cell invasion is promoted by CAFs via direct interactions with epithelial cancer cells and stage-specific, cathepsin H-dependent ECM remodeling. RNA sequencing data of the 10 NF-T1CAF pairs can be found under GEO accession number GSE200660.

Identifiants

pubmed: 37085135
pii: S2352-345X(23)00055-3
doi: 10.1016/j.jcmgh.2023.04.004
pmc: PMC10230010
pii:
doi:

Substances chimiques

Cathepsin H EC 3.4.22.16

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-131

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Hao Dang (H)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Tom J Harryvan (TJ)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Chen-Yi Liao (CY)

Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.

Erik H J Danen (EHJ)

Division of Drug Discovery and Safety, Leiden Academic Centre of Drug Research, Leiden University, Leiden, The Netherlands.

Vienna N L N Spalburg (VNLN)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Szymon M Kielbasa (SM)

Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Hailiang Mei (H)

Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Jelle J Goeman (JJ)

Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.

Eveline S de Jonge-Muller (ES)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Stefanus G T Janson (SGT)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Johan J van der Reijden (JJ)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Stijn Crobach (S)

Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

James C H Hardwick (JCH)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Jurjen J Boonstra (JJ)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.

Noel F C C de Miranda (NFCC)

Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.

Lukas J A C Hawinkels (LJAC)

Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: l.j.a.c.hawinkels@lumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH